753 related articles for article (PubMed ID: 19137534)
61. [Antimycobacterial effects of pyrrolidinoethylester alkoxysubstituted phenylcarbamic acids].
Waisser K; Cizmárik J; Drazková K; Kaustová J
Ceska Slov Farm; 2002 May; 51(3):140-4. PubMed ID: 12058355
[TBL] [Abstract][Full Text] [Related]
62. Synthesis and antimycobacterial activity of azetidine-, quinazoline-, and triazolo-thiadiazole-containing pyrazines.
Bonde CG; Peepliwal A; Gaikwad NJ
Arch Pharm (Weinheim); 2010 Apr; 343(4):228-36. PubMed ID: 20205198
[TBL] [Abstract][Full Text] [Related]
63. Antimycobacterial activity of piperidinylpropyl esters of alkoxy-substituted phenylcarbamic acids.
Waisser K; Drazková K; Cizmárik J; Kaustová J
Folia Microbiol (Praha); 2003; 48(5):585-7. PubMed ID: 14976713
[TBL] [Abstract][Full Text] [Related]
64. Discovery of novel 5-(ethyl or hydroxymethyl) analogs of 2'-'up' fluoro (or hydroxyl) pyrimidine nucleosides as a new class of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium avium inhibitors.
Shakya N; Srivastav NC; Bhavanam S; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
Bioorg Med Chem; 2012 Jul; 20(13):4088-97. PubMed ID: 22664188
[TBL] [Abstract][Full Text] [Related]
65. [Derivatives of phenylcarbamic acid as potential antituberculotics].
Waisser K; Cizmárik J
Ceska Slov Farm; 2012 Feb; 61(1-2):17-20. PubMed ID: 22536648
[TBL] [Abstract][Full Text] [Related]
66. New fluorine-containing hydrazones active against MDR-tuberculosis.
Vavříková E; Polanc S; Kočevar M; Horváti K; Bosze S; Stolaříková J; Vávrová K; Vinšová J
Eur J Med Chem; 2011 Oct; 46(10):4937-45. PubMed ID: 21855181
[TBL] [Abstract][Full Text] [Related]
67. 3'-bromo analogues of pyrimidine nucleosides as a new class of potent inhibitors of Mycobacterium tuberculosis.
Shakya N; Srivastav NC; Desroches N; Agrawal B; Kunimoto DY; Kumar R
J Med Chem; 2010 May; 53(10):4130-40. PubMed ID: 20420370
[TBL] [Abstract][Full Text] [Related]
68. Synthesis and antituberculosis activity of some N-pyridyl-N'-thiazolylhydrazine derivatives.
Turan-Zitouni G; Kaplancikli ZA; Ozdemir A
Eur J Med Chem; 2010 May; 45(5):2085-8. PubMed ID: 20149489
[TBL] [Abstract][Full Text] [Related]
69. Pentacyclo-undecane derived cyclic tetra-amines: synthesis and evaluation as potent anti-tuberculosis agents.
Onajole OK; Govender K; Govender P; van Helden PD; Kruger HG; Maguire GE; Muthusamy K; Pillay M; Wiid I; Govender T
Eur J Med Chem; 2009 Nov; 44(11):4297-305. PubMed ID: 19679378
[TBL] [Abstract][Full Text] [Related]
70. 1,3-Azoles from ortho-naphthoquinones: synthesis of aryl substituted imidazoles and oxazoles and their potent activity against Mycobacterium tuberculosis.
Moura KC; Carneiro PF; Pinto Mdo C; da Silva JA; Malta VR; de Simone CA; Dias GG; Jardim GA; Cantos J; Coelho TS; da Silva PE; da Silva EN
Bioorg Med Chem; 2012 Nov; 20(21):6482-8. PubMed ID: 23000294
[TBL] [Abstract][Full Text] [Related]
71. Synthesis of new quinoxaline-2-carboxylate 1,4-dioxide derivatives as anti-Mycobacterium tuberculosis agents.
Jaso A; Zarranz B; Aldana I; Monge A
J Med Chem; 2005 Mar; 48(6):2019-25. PubMed ID: 15771444
[TBL] [Abstract][Full Text] [Related]
72. Development of antitubercular compounds based on a 4-quinolylhydrazone scaffold. Further structure-activity relationship studies.
Gemma S; Savini L; Altarelli M; Tripaldi P; Chiasserini L; Coccone SS; Kumar V; Camodeca C; Campiani G; Novellino E; Clarizio S; Delogu G; Butini S
Bioorg Med Chem; 2009 Aug; 17(16):6063-72. PubMed ID: 19620006
[TBL] [Abstract][Full Text] [Related]
73. Synthesis, structure, and antimycobacterial activity of 6-[1(3H)-isobenzofuranylidenemethyl]purines and analogs.
Braendvang M; Bakken V; Gundersen LL
Bioorg Med Chem; 2009 Sep; 17(18):6512-6. PubMed ID: 19709890
[TBL] [Abstract][Full Text] [Related]
74. Synthesis, biological activity, and SAR of antimycobacterial 2- and 8-substituted 6-(2-furyl)-9-(p-methoxybenzyl)purines.
Braendvang M; Gundersen LL
Bioorg Med Chem; 2007 Nov; 15(22):7144-65. PubMed ID: 17804243
[TBL] [Abstract][Full Text] [Related]
75. QSAR analysis of salicylamide isosteres with the use of quantum chemical molecular descriptors.
Dolezal R; Van Damme S; Bultinck P; Waisser K
Eur J Med Chem; 2009 Feb; 44(2):869-76. PubMed ID: 18547684
[TBL] [Abstract][Full Text] [Related]
76. Synthesis of new sugar derivatives and evaluation of their antibacterial activities against Mycobacterium tuberculosis.
Horita Y; Takii T; Chiba T; Kuroishi R; Maeda Y; Kurono Y; Inagaki E; Nishimura K; Yamamoto Y; Abe C; Mori M; Onozaki K
Bioorg Med Chem Lett; 2009 Nov; 19(22):6313-6. PubMed ID: 19828313
[TBL] [Abstract][Full Text] [Related]
77. Synthesis and antituberculosis activity of new hydrazide derivatives.
Kaplancikli ZA; Turan-Zitouni G; Ozdemir A; Teulade JC
Arch Pharm (Weinheim); 2008 Nov; 341(11):721-4. PubMed ID: 18720343
[TBL] [Abstract][Full Text] [Related]
78. Synthesis of novel [1,2]-diamines with antituberculosis activity.
Meng Q; Luo H; Chen Y; Wang T; Yao Q
Bioorg Med Chem Lett; 2009 Sep; 19(18):5372-5. PubMed ID: 19682895
[TBL] [Abstract][Full Text] [Related]
79. Synthesis and in vitro anti Mycobacterium tuberculosis activity of a series of phthalimide derivatives.
Santos JL; Yamasaki PR; Chin CM; Takashi CH; Pavan FR; Leite CQ
Bioorg Med Chem; 2009 Jun; 17(11):3795-9. PubMed ID: 19427791
[TBL] [Abstract][Full Text] [Related]
80. A new modification of anti-tubercular active molecules.
Imramovský A; Polanc S; Vinsová J; Kocevar M; Jampílek J; Recková Z; Kaustová J
Bioorg Med Chem; 2007 Apr; 15(7):2551-9. PubMed ID: 17306980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
